Sector ratings Charles River Laboratories International, Inc. Berne S.E.

Stocks

End-of-day quote Berne S.E. 04/09/2026			5-day change	1st Jan Change
234.24 ^CHF	+0.11%		-3.32%	-

08-21	Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing	MT
08-20	Charles River, Medigen Partner on Multivalent Enterovirus Vaccine	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LONZA GROUP AG	50.35B		AAA
REVOLUTION MEDICINES, INC.	45.2B	-	B	-	-
IQVIA HOLDINGS INC.	44.71B		AAA
BEONE MEDICINES AG	41.24B		-
CELLTRION, INC.	33.08B		A
ASCENDIS PHARMA A/S	17.81B	-	-	-	-
MEDPACE HOLDINGS, INC.	16.56B		BBB
EUROFINS SCIENTIFIC SE	14.82B		AA
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	14B		AA
ICON PUBLIC LIMITED COMPANY	12.62B		AAA
BIO-TECHNE CORPORATION	11.36B		AA
TEMPUS AI, INC.	11.67B		A		-
PHARMARON BEIJING CO., LTD.	10.81B		AA
ABIVAX	10.78B	-	BBB	-	-
IONIS PHARMACEUTICALS, INC.	9.66B	-	A	-	-
GENSCRIPT BIOTECH CORPORATION	10.13B		AA		-
PRAXIS PRECISION MEDICINES, INC.	9.92B	-	B	-	-
KYMERA THERAPEUTICS, INC.	9.75B	-	BBB	-	-
PROTAGONIST THERAPEUTICS, INC.	9.63B		BB		-
Average	20.21B		A
Weighted average by Cap.			A